 |
Recombinant truncated SPINT2 protease inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2005-06-24 00:00:00 |
| Sponsor | Aerovance, Inc.;2929 Seventh Street;Berkeley, California, 94710 |
Related Access Program